MSH2 and urinary bladder carcinoma: Overexpression of MMR proteins is also linked to poor survival in oral squamous carcinoma (MSH2, MSH6) [14], bladder cancer (MLH1) [15], Stage I–II colon cancer (MLH1) [16] and Stage I–III melanoma (MSH6) [17].